Origen de la red de primer grado Barbara Brunnhuber.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Mireca Medicines GmbH
Mireca Medicines GmbH Pharmaceuticals: MajorHealth Technology Mireca Medicines GmbH develops treatment for hereditary eye disease. The company was founded by François Paquet-Durand, Pieter Jaap Gaillard and Barbara Brunnhuber in 2017 and is headquartered in Tubingen,
4
| Holding Company | Pharmaceuticals: Major | 4 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Barbara Brunnhuber a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
University of Leiden | College/University | Doctorate Degree Doctorate Degree | |
University of Utrecht | College/University | Graduate Degree | |
Apotek Produktion & Laboratorier AB
Apotek Produktion & Laboratorier AB Pharmaceuticals: MajorHealth Technology Apotek Produktion & Laboratorier AB develops and manufactures pharmaceutical products. Its services include analytical services, clinical trials and contract manufacturing. The company is headquartered in Kungens Kurva, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Hult International Business School | College/University | Masters Business Admin | |
Stockholm Brain Institute | Chairman | ||
Valneva Sweden AB
Valneva Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers. | Biotechnology | Chief Executive Officer | |
ALZECURE PHARMA AB | Biotechnology | Director/Board Member | |
NorthX Biologics Matfors AB
NorthX Biologics Matfors AB BiotechnologyHealth Technology NorthX Biologics Matfors AB is a biologics company that specializes in high-quality protein production and DNA manufacturing. The company is based in Matfors, Sweden, and has subsidiaries in Sweden. The Swedish company offers comprehensive cell banking services, including master cell bank production, GMP cell banking, and cell bank characterization, ensuring quality and compliance for biological products. The company also provides premium plasmid DNA services, offering GMP, High Quality, and Research Grade plasmids for gene therapy, cell therapy, molecular biology research, and clinical applications. The company was founded in 1963, and Janet Hoogstraate has been the CEO of the company since 2023. | Biotechnology | Chief Executive Officer | |
Hoogstraate Consulting AB. | Chief Executive Officer | ||
The Dutch Chamber of Commerce In Sweden | Director/Board Member |
Estadísticas
Internacional
Suecia | 8 |
Países Bajos | 4 |
Emiratos Árabes Unidos | 2 |
Sectorial
Health Technology | 6 |
Consumer Services | 4 |
Operativa
Director/Board Member | 6 |
Founder | 3 |
Chief Executive Officer | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 2 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Barbara Brunnhuber
- Conexiones Empresas